Pulmatrix, Inc. (NASDAQ:PULM – Get Rating) was the target of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 1,300 shares, a drop of 55.2% from the April 15th total of 2,900 shares. Based on an average daily volume of 18,500 shares, the days-to-cover […]
Pulmatrix, Inc. (NASDAQ:PULM – Get Rating) was the target of a large decline in short interest in April. As of April 30th, there was short interest totalling 1,300 shares, a decline of 55.2% from the April 15th total of 2,900 shares. Based on an average trading volume of 18,500 shares, the days-to-cover ratio is currently […]
StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a research report sent to investors on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $10.00 price target on shares of Pulmatrix in a research report on Tuesday, […]
Pulmatrix, Inc. (NASDAQ:PULM – Get Rating) saw a significant decrease in short interest in April. As of April 30th, there was short interest totalling 1,300 shares, a decrease of 55.2% from the April 15th total of 2,900 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 18,500 […]
StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a report released on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $10.00 target price on shares of Pulmatrix in a report on Tuesday, February 7th. Pulmatrix Trading Up […]